FCRL3 and type 1 diabetes mellitus: Accumulating evidence gathered from multiple populations supports the effect of polymorphisms in non-HLA genes, such as PTPN22, FCRL3 (25) and vitamin D receptor gene (26), on modulating beta-cell function in T1D subjects.